
New WHO report highlights barriers to insulin for diabetes
A new report highlights the worrying state of global access to insulin for diabetes care and finds that high prices, low availability of human insulin, few producers dominating the insulin market and weak health systems are the main barriers to universal access.
Insulin for diabetes treatment is essential for diagnosed individuals to manage their condition, reducing fatality rates, risk of kidney failure, blindness and limb amputation for people living with type 1 and type 2 diabetes.
“The scientists who discovered insulin 100 years ago refused to profit from their discovery and sold the patent for just one dollar,” said WHO Director-General, Dr Tedros Adhanom Ghebreyesus. “Unfortunately, that gesture of solidarity has been overtaken by a multi-billion-dollar business that ...